NYSE: CLX

Clorox (CLX) Stock Analysis & Forecast

Sep 28 close

$81.42−2.38 (−2.8%)

Gekko Brief

AI summary

This week Clorox launched Clorox Purell ProCare, a new B2B platform combining CloroxPro with GOJO, the maker of Purell, aimed at professional and healthcare hygiene customers. Alongside this, Clorox raised its quarterly dividend to $1.25 per share, an annualized rate of $5, even as commentary pointed to an 85% payout ratio described by management as elevated, a 33% stock price decline over the past year, and continued inflation, weak volume growth and integration risk tied to the GOJO acquisition. The stock also drew attention for trading at a 14x forward P/E with a 6% dividend yield.

Clorox closed at $81.42, down 2.8%, and sits below both its 50-day average of $96.78 and 200-day average of $101.82, with the 50-day below the 200-day. The GekkoIndex reads 66.7, placing it in the Accumulation zone, though the reading has moved -5.3 over five days. Price stands 46.4% below the Gekko Fair Value of $152.03.

Over the next 20 trading days, the next earnings report falls on 3 November 2026, 35 days out, after the last quarter's EPS of $1.66 beat the $1.64 estimate and produced a 9.6% reaction. In the last 30 days there has been 1 unusual options signal, with call premium of $380,285 and no put premium. Consensus among 13 firms shows 0 buy, 9 hold and 4 sell ratings, with a consensus target of $100.76. Seasonally, the next 20 trading days have averaged -3.6% over 5 years, rising in 1 of them.

Written by AI and checked automatically against the figures on this page. Generated Sep 29, 2026 from the data above.

Clorox price vs fair value

$152.03$81.42Sep ’25Mar ’26Sep ’26
Close $81.42200-day averageGekko Fair Value $152.03

Clorox quick facts

Market cap
$9.85B
P/E ratio
17.4
Forward P/E
15
EPS, TTM
$4.81
Revenue, TTM
$6.72B
Profit margin
8.7%
Dividend yield
6.08%
Beta
0.54
Volume
3.19M avg 3.70M
1-year return
−33.6%
Typical daily move
±3.2%
Typical 20-day move
±4.7%
50-day average
$96.78
200-day average
$101.82
Next earnings
Nov 3 after close
Shares outstanding
120.9M
52-week range
$80.84$128.90

Clorox swing-trade checklist

Clorox scores 4 supportive, 0 mixed and 2 headwinds across the 6 checklist items with data.

Six things swing traders check before a 20-day hold, read from the latest data.

4 supportive0 mixed2 headwinds

  • Trendheadwind

    Below 50 and 200-day

    Close $81.42 is below the 50-day ($96.78) and 200-day ($101.82) averages, and the 50-day is below the 200-day.

    See the chart
  • GekkoIndexsupportive

    66.7, Accumulation

    Reading 66.7 is in the Accumulation zone.

    See the GekkoIndex
  • Fair valuesupportive

    46.4% below

    Price is 46.4% below Gekko Fair Value (more than 5% below).

    See fair value
  • Smart moneysupportive

    Leans bullish

    Last 30 days: 1 unusual options signal.

    See smart money
  • Earnings risksupportive

    Reports in 35 days

    Next report Nov 3, 2026, 35 days away — outside a typical 20-trading-day hold.

    See earnings
  • Seasonalityheadwind

    −3.6% on average

    From this point in the calendar, the next 20 trading days averaged −3.6% over 5 years, rising in 1 of them.

    See seasonality

A description of current data, not a recommendation. How this page works

Clorox stock chart and price history

Clorox closed at $81.42 on Sep 28, 2026, −33.6% over the past year, inside a 52-week range of $80.84 to $128.90.

Close50-day average200-day averageVolume
Clorox share price, past year, with 50-day and 200-day moving averages and volume$100$120$140NovDecJan 2026FebMarAprMayJunJulAugSep81.42

Use the left and right arrow keys to read daily values.

Performance Breakdown

1 month
−21.4%
3 months
−16.1%
6 months
−20.2%
1 year
−33.6%
The full CLX chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open CLX in Gekko

Follow Clorox through every session

Put CLX on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.

Track CLX in GekkoFree for 7 days. No credit card required.

About Clorox

Clorox makes and sells a wide range of household and professional goods, spanning cleaning supplies, disinfectants, laundry additives, and personal care items. It is widely recognized for well-known names such as Clorox, Pine-Sol, Glad, Kingsford, Brita, and Burt's Bees, which appear on store shelves across many categories from home care to food storage to grilling.

The company organizes its operations into four segments: Health and Wellness, Household, Lifestyle, and International. Health and Wellness covers cleaning and disinfecting products for both homes and professional settings, along with vitamins and supplements sold under labels like RenewLife and NeoCell. Household focuses on cat litter, bags and wraps, and charcoal for the U.S. market, while Lifestyle includes dressings, sauces, natural personal care items, and water filtration systems. The International segment carries a similar mix of products under region-specific and global brand names. Clorox reaches shoppers through retailers, grocery and warehouse stores, pharmacies, pet shops, military exchanges, e-commerce sites, distributors, and its own sales force.

Founded in 1913, Clorox is headquartered in Oakland, California. Its shares are listed on the NYSE under the ticker CLX.

Listed
NYSE
Sector
Consumer non-durables
Industry
Household/Personal care
Website
thecloroxcompany.com

Clorox GekkoIndex: the smart money zone

Clorox’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 66.7, in the Accumulation zone, down 5.3 points over five sessions.

010066.7Accumulation

Down 5.3 points over five sessions, from the Buying zone.

Reading for Sep 28, 2026

What followed past readings in each zone

ZoneReadings5 days10 days20 days50 days
Buying53−1.0%−0.6%+0.1%+1.2%
Accumulation (current zone)310−0.2%−0.9%−1.5%−2.5%
Neutral278−0.5%−0.7%−1.2%−3.6%
Distribution29+0.8%+1.8%−0.9%−6.9%
Selling2Too few readings yet

Average CLX share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Accumulation readings averaged +2.3% over 20 days. Past behaviour doesn’t guarantee future results.

Accumulation zone: Institutional interest building. About the five zones →

See every daily GekkoIndex reading plotted over the CLX price, zone by zone.Track CLX in Gekko

Is Clorox stock overvalued? Gekko Fair Value

Clorox trades 46.4% below Gekko Fair Value of $152.03, so the shares are undervalued on Gekko’s estimate.

Gekko’s own estimate of what Clorox shares are worth, recalculated every trading day.

$152.03

Gekko Fair Value, Sep 29, 2026

46.4% Undervalued

How Gekko Fair Value works →

Gekko Fair Value on every chart, with the gap to price updating daily.Open CLX in Gekko

Clorox insider and Congress trading

No open-market insider purchases were filed for Clorox, and no Congress trades were disclosed, in the last 90 days.

Plus buybacks, unusual options and fund positions, each dated to when it became public.

Insider buying last 90 days

No open-market insider purchases were filed for CLX in the last 90 days.

From Form 4 filings, dated to when each was filed.

Every CLX insider filing, plotted on the chart in Gekko.Open CLX in Gekko

Congress trades last 90 days

No trades in CLX were disclosed by members of Congress in the last 90 days.

From congressional disclosures, which report amounts as ranges.

Congress disclosures for CLX, plotted on the chart in Gekko.Open CLX in Gekko

Buybacks

Clorox has been buying back its own shares.

Bought back, quarter ended Mar 31, 2026
$270.0M
As a share of market cap
2.74%
Trailing four quarters
$601.0M

From company filings.

Unusual options activity last 30 days

1signal, 100% of the flagged premium in calls.

Latest: Bullish flow on Sep 12, $380K in unusual premium.

Hedge funds and billionaires quarter ended Jun 30

2of the funds Gekko tracks hold CLX.

2added0opened0trimmed0sold out
Every signal with its contract, strike and premium, and which funds are on each side.Unlock in Gekko

Clorox earnings: next date and track record

Clorox reports on Nov 3, 2026, after the close (35 days away), and beat the EPS estimate in 6 of its last 8 reports.

6 of 8reports beat the EPS estimate
±4.6%average move across the report
3 of 8reports followed by a gain

Share-price move across each report

+1.1%Oct ’24−6.6%Feb ’25−2.9%May ’25−2.4%Jul ’25−1.8%Nov ’25+4.0%Feb ’26−8.1%Apr ’26+9.6%Aug ’26

Last earnings call, Aug 3, 2026 AI summary

What they said
Clorox reported operating in a challenging FY26 marked by value-seeking consumers, competitive activity, inflation and macro uncertainty. Management highlighted sequential improvement across the year, with most businesses at or above expectations and notable share gains in Home Care, Pro & International, Glad and Hidden Valley Ranch. The GOJO (Purell) acquisition is integrating well, performing ahead of plan and expected to be accretive to adjusted EPS next year. Management completed an ERP implementation and expects ERP-enabled productivity and optimization to drive future efficiencies. For FY27, the company expects a muted category environment, flat to slightly positive organic sales, elevated promotional levels similar to pre-COVID historic norms, and meaningful inflationary headwinds (> $200 million) concentrated in the first half (Brent assumption ~$90/bbl). Management intends to use productivity, targeted/strategic pricing, price-pack architecture, and brand investments to offset inflation and recover gross margin in the back half of FY27. The company reaffirmed its dividend policy, expects free cash flow in a target range of ~11%–13% of sales, and sees GOJO growing mid-single digits and accretive. Management emphasized disciplined portfolio review, targeted reinvestments to drive superiority, and plans to continue category and market share initiatives.
Guidance
Fiscal 2027: organic sales flat to up slightly; fiscal 2027 inflation > $200 million (assumes Brent crude ~ $90/bbl) with headwinds concentrated in first half; gross margin guidance referenced at ~42% (management noted recovery expected in back half); free cash flow target ~11%–13% of sales; GOJO expected to grow mid-single digits and be accretive to adjusted EPS; interest expense ~ $210 million. Management provided an EPS range (not specified in transcript) and indicated it is wider than usual due to timing and volatility.
Risks flagged
Persisting commodity, energy and logistics inflation; geopolitical uncertainty (e.g., Middle East); softer category demand driven by consumer value-seeking; elevated promotional environment; weather-driven seasonality impacts (e.g., grilling/Kingsford); competitive activity and private label pressure in certain categories (bags, litter); ERP/timing-related implementation noise (largely stabilized but still being optimized); CEO transition/search risk. (Also standard SEC-filed forward-looking risk disclosures apply.)
ReportedEPSSurpriseRevenueSurpriseMove
Aug 3, 2026$1.66
est $1.64
+1.2%$1.95B
est $1.91B
+1.7%+9.6%
Apr 30, 2026$1.64
est $1.55
+5.8%$1.67B
est $1.67B
0.0%−8.1%
Feb 3, 2026$1.39
est $1.43
−2.8%$1.67B
est $1.64B
+2.0%+4.0%
Nov 3, 2025$0.85
est $0.82
+3.9%$1.43B
est $1.40B
+2.1%−1.8%
Jul 31, 2025$2.87
est $2.20
+30.5%$1.99B
est $1.93B
+3.1%−2.4%
May 5, 2025$1.45
est $1.55
−6.5%$1.67B
est $1.72B
−2.7%−2.9%
Feb 3, 2025$1.55
est $1.39
+11.5%$1.69B
est $1.76B
−4.3%−6.6%
Oct 30, 2024$1.86
est $1.41
+31.9%$1.76B
est $1.65B
+6.9%+1.1%

“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.

Clorox stock forecast and analyst price targets

Analysts’ average 12-month price target for Clorox is $100.76, +23.8% from the last close, from 13 firms rating the stock in the last 90 days.

$100.76consensus 12-month target, +23.8% from the last close
Low $77High $118
Buy0
Hold9
Sell4

Each firm’s latest rating in the last 90 days: 13 firms.

Latest analyst actions

DateFirmRatingTargetvs price
Sep 18Bank of America SecuritiesHold, maintained$100+22.8%
Sep 11CitiHold, maintained$97+19.1%
Sep 11Evercore ISISell, maintained$99+21.6%
Sep 11Bank of America SecuritiesHold, maintained$100+22.8%
Sep 11Wells FargoHold, maintained$90+10.5%
−1.5%average 20-day move after past Accumulation readings
−3.6%average move over the next 20 trading days in the last 5 years
±3.2%typical daily move, from the 14-day average range

Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.

Clorox seasonality: the next 20 trading days

Over the next 20 trading days from Sep 29, Clorox averaged −3.6% across the last 5 years, rising in 1 of them.

Next 20 trading days, by year

−5.1%2021+7.5%2022−10.0%2023−3.2%2024−6.1%2025

Average move and hit rate

WindowAverageYears higher
Next 5 trading days−2.7%0 of 5
Next 10 trading days−3.3%0 of 5
Next 15 trading days−2.8%0 of 5
Next 20 trading days−3.6%1 of 5
Next 30 trading days−1.1%3 of 5

For scale, CLX’s typical 20-trading-day move in either direction is about 4.7%.

Clorox market cap and key statistics

Clorox’s market cap is $9.85B, with a P/E ratio of 17.4 and revenue of $6.72B over the last twelve months.

Valuation

Market cap
$9.85B
P/E ratio
17.4
Forward P/E
15
EPS, TTM
$4.81
Gekko Fair Value
$152.03

Trading

Volume
3.19M
Avg volume, 20 days
3.70M
52-week high
$128.90
52-week low
$80.84
Shares outstanding
120.9M

Financials

Revenue, TTM
$6.72B
Profit margin
8.7%
Return on equity
163.8%
Quarterly earnings growth, YoY
−50.1%

Risk and income

Beta
0.54
Typical daily move
±3.2%
Typical 20-day move
±4.7%
Dividend yield
6.08%

Clorox peers

Clorox’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.

StockTodayGekkoIndex zonevs Fair Value
PGProcter & Gamble+2.2%Neutral11.3% below
CLColgate-Palmolive+1.0%Accumulation1.8% below
ELEstee Lauder Companies+2.9%Neutral5.7% above
KVUEKenvue+0.9%Accumulation19.5% below
KMBKimberly-Clark+0.8%Accumulation14.9% below
CHDChurch & Dwight−0.2%Accumulation3.8% below

A peer links to its own page where one exists.

In the Buying zone today

Reporting earnings this week

Popular on Gekko

Clorox stock FAQ

What is Clorox’s market cap?

Clorox’s market cap is $9.85B at the Sep 28, 2026 close of $81.42, with 120.9M shares outstanding. The shares trade on a P/E ratio of 17.4.

What is the Clorox stock forecast?

The consensus analyst 12-month price target for Clorox is $100.76, +23.8% from the last close. Of the 13 firms that rated the stock in the last 90 days, 0 rate it a buy, 9 a hold and 4 a sell. Gekko doesn’t publish price predictions of its own.

Is Clorox stock overvalued or undervalued?

On Gekko’s estimate Clorox is undervalued: the Sep 28, 2026 close of $81.42 is 46.4% below Gekko Fair Value of $152.03. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.

When does Clorox report earnings next?

Clorox is expected to report on Nov 3, 2026, after the market closes (35 days away). Analysts expect earnings of $1.11 per share on revenue of $1.88B. Clorox beat the earnings estimate in 6 of its last 8 reports, moving 4.6% on average across the report.

What is Clorox’s 52-week high and low?

Clorox’s 52-week high is $128.90 and its 52-week low is $80.84; it closed at $81.42 on Sep 28, 2026, −33.6% over the past year. Over the last five years the shares peaked at $186.86 on Jan 14, 2022.

Is Clorox stock a buy right now?

Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 4 of the 6 items with data read as supportive (gekkoindex, fair value, smart money and earnings risk) and 2 as headwinds (trend and seasonality). The checklist is a description of current data, not a recommendation.

Is there unusual options activity in Clorox?

Gekko flagged 1 unusual options signal in Clorox over the last 30 days, with $380K of flagged premium in calls and $0 in puts. The latest, bullish flow, was on Sep 12, 2026 with $380K in unusual premium. The signal-by-signal table is in Gekko.

How this page works

During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →

See Clorox the way Gekko members do

Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.

Join 1,380 other traders using Gekko

Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.